Croda Singapore expands pastille-format manufacturing capacity

Croda International has inaugurated a speciality chemicals manufacturing facility at its Seraya site, on Jurong Island, Singapore.

The pastillator 4 (PS04) unit enables Croda to meet the growing global demand for pastille-format alkoxylates and ester, with easier and safer for customer handling across consumer care, life sciences and industrial markets.

The 22m Singapore dollar ($16.4m) investment will expand the production capacity by an additional 4,600 metric tonnes of pastille products.

In total, the site has a production capacity of 15,000 metric tonnes.

Croda says the facility reduces lead-time for customers and supports Croda’s growth, innovation and sustainability targets.

“Since inception, Croda Singapore has consistently invested in the Seraya site to ensure safe operations. Manufacturing quality, sustainable ingredients based on our customers’ needs is our competitive advantage,” said Croda Singapore managing director Babu Alagappan.

“Our investment allows us to fulfil growing demand for pastilles. This adds to Croda’s innovative range of speciality chemicals that also supports our sustainability targets,” he added.

“We are extremely proud to highlight the fact that this project has been delivered on time, on cost and without any lost time injury. This is a commendable achievement by the entire Croda team and its partners.”

Latest Issues

9th Anti-Ageing Skin Care Conference

Royal College of Physicians, London
25th - 26th June 2024

in-cosmetics Korea 2024

Hall C, Coex, Seoul, South Korea
24th - 26th July 2024